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1. Introduction 
The metabolism of the serum lipoproteins may be 
a function of their composition and structure, which 
can be altered under different nutritional and patho- 
logical conditions. It has been shown that the associa- 
tion of VLDL and HDL apoproteins with lipid are 
dependent upon the fluidity of the lipid [1-5]. In 
addition, the ability of the hydrolytic enzyme lipo- 
protein lipase to hydrolyze its substrate, VLDL, may 
be dependent on the physical state of the surface 
lipid [6]. To elucidate the surface structure of VLDL, 
we have utilized the fluorescence probes ~-parinaric 
acid (all trans-9,11,13,15-octadecatetraenoic cid) 
03-P) and diphenylhexatriene (DPH), a new quenching 
agent rinitrophenylglycine (glycine-TNP), and a com- 
puter-centered spectrofluorimeter. The fluorescent 
probe molecules ~3-parinaric a id and 1,6-diphenyl- 
1,3,5-hexatriene w re incorporated into the very low 
density lipoprotein (VLDL) enriched with oleate by 
perfusion of the isolated rat liver in vitro. The fluo- 
rescence mission of both probe molecules overlapped 
with the absorption spectrum of trinitrophenyl- 
glycine. Trinitrophenylglycine maximally quenched 
fluorescence of~-parinarate and diphenylhexatriene 
in VLDL, 94% and 20%, respectively. Thus, trinitro- 
phenylglycine did not penetrate the surface of the 
VLDL and appeared to quench only those diphenyl- 
hexatriene molecules near the surface. In contrast, 
the almost complete quenching of ~-parinarate indi- 
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cated that the/3-parinarate was exclusively located in 
the surface. The results were consistent with the 
existence of monolayer surrounding an interior core 
structure for VLDL. 
2. Materials and methods 
The fluorescence probes/3-parinaric acid and 
1,6-diphenyl-1,3,5-hexatriene w r  obtained from 
Molecular Probes Inc., Roseville, MN, and from 
Aldrich Chemical Co., Milwaukee, WI. Trinitro- 
phenylglycine (glycine-TNP) was synthesized from 
2,4,6-trinitrobenzenesulfonate a d glycine (Sigma 
Chemical Co., St Louis, MO) as in [7]. The very low 
density lipoprotein was isolated from the medium 
following perfusion of the rat liver in vitro. The liver 
was perfused with a blood-free medium containing 
purified bovine serum albumin bound to oleate as in 
[8,9]. 
The fluorescence probe molecule,/3-parinaric cid 
was incorporated into the VLDL (50 ~g lipid/ml phos- 
phate-buffered 0.9% NaC1, pH 7.4) as in [10]. The 
1,6-diphenyl-1,3,5-hexatriene (0.5/~g/ml) was 
incorporated into the VLDL (50/.tg lipid/m1) 
resuspended in phosphate-buffered saline, (pH 7.4) 
as in [ 11 ]. The computer-centered spectrofluorimeter 
in [ 12,13] was usedto measure absorbance, absorbance 
corrected fluorescence (corrected for the inner filter 
effect), relative fluorescence efficiency, corrected 
fluorescence emission, and light scattering corrections 
as in [14,15]. Excitation for ~-parinaric acid and 
1,6-diphenylhexatriene was measured at 313 nm and 
362 nm, respectively, while emission was measured 
at 420 nm and 424 nm, respectively. 
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3. Results and discussion 
Fluorescence probe molecules are used as reporter 
groups in membrane biology. However, the locations 
of probe molecules are understood in a qualitative 
sense only. Spin-labelled and fluorescent-labelled fatty 
acids are located in the surface of HDL, LDL or 
mammalian membranes with their carboxyl ends at 
the water-membrane lipid interface [1 6,17]. Thus, 
~-parinaric acid would be expected to orient in a 
similar fashion in VLDL. In contrast, 1,6-diphenyl- 
1,3,5-hexatriene has been used to measure 'core 
properties' of lipoproteins [1 1 ]. To determine the 
location ('surface' or 'core') of these probes we 
utilized a novel chemical quenching reagent glycine- 
TNP. As shown in fig. 1, trinitrobenzenesulfonate 
(TNBS) has an A 340 max. Upon reaction with the 
free amino group of glycine, the A34o increases and a 
new A49_ o max appears. Since the latter absorption 
peak overlaps with the fluorescence emission of 
fl-parinaric acid in the VLDL and since glycine-TNP 
itself does not fluoresce, this molecule should be 
an excellent quencher of/3-parinaric acid fluorescence 
if the following conditions are also met: 
(i) The ~-parinaric acid is located close to the 
surface of  the VLDL such that quenching can 
occur. Energy transfer quenching is proportional 
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Fig.2. Effect of glycine-TNP on shape of ~-parinarate corrected 
fluorescence emission spectrum. All curves represent 
j3-parinarate fluorescence emission in VLDL in the presence 
of increasing concentrations of glycine-TNP. 
(ii) The quenching is non-trivial; that is, it must not 
be reabsorption of  emitted light. 
(iii) Glycine-TNP does not penetrate into the VLDL 
'interior core'. 
Condition (ii) can easily be satisfied as follows. 
Figure 1 indicates that if non-trivial quenching occurs, 
then the left side of  the f3-parinarate emission peak 
should be quenched more than the right side. However, 
as shown in fig.2 the shape of the fluorescence curve 
does not change with increasing concentration of 
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Fig.1. Overlap of glycine-TNP absorption with #-parinaric 
acid fluorescence emission. All conditions were as in sec- 
tion 2. ( . . . .  ) is 4 mM 2,4,6-trinitrobenzenesulfonic acidin 
PBS; ( ) is 72 tzM glycine-TNP in PBS; ( . . . . .  ) is the 
absorption spectrum (260-340 nm) and corrected fluo- 
rescence mission spectrum (340-540 nm) of #-parinarate 
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Fig. 3. Quenching of/3-parinaric acid (#-P) 1,6-diphenyl-1,3,5- 
hexatriene fluorescence (DPH) in VLDL by glycine-TNP. 
~-P or DPH were incorporated into VLDL as in section 2. 
Quenching of corrected fluorescence emission was measured 
in the presence of increasing concentrations ofglycine-TNP. 
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The fluorescence of/3-parinarate is maximally 
quenched at 72 M glycine-TNP (94% quench). Thus, 
all of the (3-parinarate must be located in one mono- 
layer of  a bilayer surrounding the VLDL triglyceride 
core or the surface of the VLDL may be a monolayer. 
The former possibility is unlikely since if the quencher 
is located only on one side of a bilayer membrane 
(LM cell plasma membrane) then only 45% of the 
~3-parinarate fluorescence is quenched (F. S. (1979) 
Nature, in press). This would indicate approximately 
equal partitioning of/3-parinarate across both mono- 
layers of  a bilayer, a process that occurs within 
1-3 rain [19]. The C1/2 (the concentration of 
quencher needed for 50% decrease in fluorescence 
yield) of glycine-TNP for/3-parinarate in VLDL is 
~20/aM. Condition (iii) is met by the fact that at 
equivalent concentrations of glycine-TNP (72 #M), 
the fluorescence of 1,6-diphenyl-1,3,5-hexatriene n 
VLDL is maximally quenched only ~20%. If  either 
~-parinarate or 1,6-diphenyl-1,3,5-hexatriene are dis- 
solved in ethanol and increasing amounts of  glycine- 
TNP are added, then fluorescence was quenched 
~95% in both cases. This indicates that the 20% 
maximal quench of  1,6-diphenyl-1,3,5-hexatriene 
fluorescence in the VLDL is not due to lower inherent 
quenching efficiency of 1,6-diphenyl-1,3,5-hexa- 
triene by glycine-TNP. 1,6-Diphenylhexatriene is 
located in the interior core of lipoproteins [ 11 ] and 
only a fraction would be expected to be near the 
surface and available for quenching by glycine-TNP 
if the quencher did not penetrate into the interior. 
However, if glycine-TNP penetrated into the interior 
it should quench with high efficiency. Thus since it 
does not quench 1,6-diphenyl- 1,3,5-hexatriene 
fluorescence more than 20%, the glycine-TNP appears 
not to penetrate the VLDL surface. Therefore, the 
results obtained here with/3-parinaric acid and 
1,6-diphenyl-1,3,5-hexatriene quenching are more 
consistent with a monolayer surface structure of 
the VLDL. A monolayer structure for the VLDL 
surface was first proposed on the basis of  chemical 
composition [20,21]. The results presented herein 
represent experimental verification consistent with 
the theoretical calculations. Such a monolayer would 
be composed of sterols, apoproteins, free fatty acids 
and phospholipid. Similar findings obtained by 
electron microscopy of chylomicrons also indicate a 
surface monolayer structure for chylomicrons [22,23]. 
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